BRUGNOLO, ANDREA
 Distribuzione geografica
Continente #
EU - Europa 12.439
NA - Nord America 1.768
AS - Asia 1.489
Continente sconosciuto - Info sul continente non disponibili 155
SA - Sud America 131
AF - Africa 36
OC - Oceania 1
Totale 16.019
Nazione #
IT - Italia 12.186
US - Stati Uniti d'America 1.667
SG - Singapore 589
CN - Cina 352
VN - Vietnam 262
BD - Bangladesh 132
FR - Francia 96
BR - Brasile 75
CA - Canada 50
HK - Hong Kong 43
GB - Regno Unito 32
DE - Germania 26
FI - Finlandia 23
AR - Argentina 21
JP - Giappone 20
IQ - Iraq 15
IN - India 14
CH - Svizzera 12
ID - Indonesia 12
EC - Ecuador 11
JM - Giamaica 11
MX - Messico 11
NL - Olanda 10
PL - Polonia 10
CR - Costa Rica 9
ES - Italia 9
PK - Pakistan 8
CO - Colombia 7
IE - Irlanda 7
ZA - Sudafrica 7
EG - Egitto 6
PH - Filippine 6
RU - Federazione Russa 6
UA - Ucraina 6
DZ - Algeria 5
MA - Marocco 5
TH - Thailandia 5
TR - Turchia 5
BS - Bahamas 4
CL - Cile 4
KE - Kenya 4
SV - El Salvador 4
TW - Taiwan 4
BO - Bolivia 3
PY - Paraguay 3
TN - Tunisia 3
UZ - Uzbekistan 3
AL - Albania 2
AT - Austria 2
BB - Barbados 2
BE - Belgio 2
GD - Grenada 2
JO - Giordania 2
LB - Libano 2
LC - Santa Lucia 2
LT - Lituania 2
OM - Oman 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
SE - Svezia 2
UY - Uruguay 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
ET - Etiopia 1
GA - Gabon 1
GF - Guiana Francese 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
KW - Kuwait 1
KZ - Kazakistan 1
MD - Moldavia 1
MM - Myanmar 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
PE - Perù 1
RO - Romania 1
SC - Seychelles 1
SI - Slovenia 1
SN - Senegal 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
Totale 15.864
Città #
Genova 6.358
Genoa 3.454
Rapallo 1.189
Vado Ligure 913
Singapore 298
San Jose 283
Ashburn 204
Ho Chi Minh City 95
Lauterbourg 78
New York 62
Beijing 59
Hanoi 58
Los Angeles 45
Santa Clara 44
Dallas 43
Hong Kong 39
Bordighera 34
Rome 32
Frankfurt am Main 23
Helsinki 23
Atlanta 20
Chicago 18
Orem 18
Montreal 17
Tokyo 17
Milan 16
Brooklyn 12
Denver 12
Houston 12
Phoenix 11
Seattle 11
Zurich 11
Council Bluffs 10
London 9
Tianjin 9
Toronto 9
Bologna 8
Buffalo 8
Detroit 8
Naples 8
Philadelphia 8
São Paulo 8
Warsaw 8
Da Nang 7
Mexico City 7
Palermo 7
San Francisco 7
Dublin 6
Hải Dương 6
Kingston 6
Madrid 6
Miami 6
Paris 6
San José 6
Turin 6
Washington 6
Amsterdam 5
Belo Horizonte 5
Boston 5
Cleveland 5
Haiphong 5
Jakarta 5
Phủ Lý 5
Pittsburgh 5
Baghdad 4
Brescia 4
Cairo 4
Cardiff 4
Charlotte 4
Douglasville 4
El Paso 4
Fort Myers 4
Guayaquil 4
Johannesburg 4
Louisville 4
Nassau 4
Taranto 4
Thái Nguyên 4
Allen 3
Alpharetta 3
Aurora 3
Bogotá 3
Changsha 3
Chennai 3
Cincinnati 3
City of London 3
Erie 3
Florence 3
Greensboro 3
Hoover 3
Huntsville 3
Jacksonville 3
Jersey City 3
Kansas City 3
Karachi 3
Lahore 3
Las Vegas 3
Minneapolis 3
North Bergen 3
Orlando 3
Totale 13.846
Nome #
Personality traits and levels of anxiety and depression among martial artists: a cross-sectional study 671
An updated Italian normative dataset for the Stroop color word test (SCWT) 277
A normative study of the Italian printed word version of the free and cued selective reminding test 234
Brain 18F-DOPA PET and cognition in de novo Parkinson's disease. 218
Visual Versus Semi-Quantitative Analysis of 18F-FDG-PET in Amnestic MCI: An European Alzheimer's Disease Consortium (EADC) Project. 218
Un nuovo parametro grafopatologico nella valutazione dello stato cognitivo: l'indice della scrittura. 209
99mTc-HMPAO and 99mTc-ECD SPECT uptake correlates of verbal memory in Alzheimer’s disease 205
MCI Patients Declining and Not-Declining at Mid-Term Follow-up: FDG-Pet Findings. 204
Brain dopaminergic (FluroDOPA PET) correlates of kinematic flexibility in Parkinson's Disease 195
Alterations in the autonomic control of heart rate variability in patients with anorexia or bulimia nervosa: correlations between sympathovagal activity, clinical features, and leptin levels 194
Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer’s disease 194
Parkinson’s Disease Sleep Scale 2: application in an Italian population 192
Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers 183
Brain perfusion correlates of cognitive and nigrostriatal functions in de novo Parkinson's disease. 183
Cortical sources of awake scalp EEG in eating disorders 182
Mapping brain morphological and functional conversion patterns in amnestic MCI: a voxel-based MRI and FDG-PET study 178
Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease 178
Functional neuroimaging and clinical features of drug naive patients with de novo Parkinson's disease and probable RBD 177
Early identification of MCI converting to AD: a FDG PET study 176
18F–FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer’s disease (AD) patients at the mild cognitive impairment (MCI) stage 176
The Short Cognitive Evaluation Battery in Cognitive Disorders of the Elderly - Italian Version. 172
What predicts cognitive decline in de novo Parkinson's disease? 168
Amnestic mild cognitive impairment in Parkinson’s disease: a brain perfusion SPECT study 167
Metabolic networks underlying cognitive reserve in prodromal Alzheimer disease: a European Alzheimer Disease Consortium project 167
The fate of patients with REM sleep behavior disorder and Mild Cognitive Impairment 167
99mTc-HMPAO and 99mTc-ECD brain distribution correlates differently with verbal memory performance in Alzheimer’s disease patients 166
The reversed Clock drawing test phenomenon in Alzheimer’s disease: a perfusion SPECT study 165
Impaired access to semantic memory for the cognition of geographic space in Alzheimer's disease. 165
Brain Resources: How Semantic Cueing Works in Mild Cognitive Impairment due to Alzheimer’s Disease (MCI-AD) 164
How legislation on decisional capacity can negatively affect the feasibility of clinical trials in patients with dementia. 159
Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease 156
The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia. 156
Epilepsy in Neurodegenerative Dementias: A Clinical, Epidemiological, and EEG Study 156
Brain dopaminergic correlates of cognitive functions in de novo parkinson’s disease: a 18FDOPA PET study. 155
Radionuclide brain imaging correlates of cognitive impairment in Parkinson's disease (PD). 154
Correlazioni SPECT-neuropsicologia nella malattia di Alzheimer iniziale 154
Frontal Variant Alzheimer Disease or Frontotemporal Lobe Degeneration With Incidental Amyloidosis? 154
Global cognitive impairment should be taken into account in SPECT-neuropsychology correlations: the example of verbal memory in very mild Alzheimer's disease. 153
Stroop interference task and single-photon emission tomography in anorexia: a preliminary report 152
Neuroimaging findings and clinical trajectories of Lewy body disease in patients with MCI 152
Plasma antioxidants and brain glucose metabolism in elderly subjects with cognitive complaints. 150
Cuneus/precuneus as a central hub for brain functional connectivity of mild cognitive impairment in idiopathic REM sleep behavior patients 150
Metabolic correlates of rey auditory verbal learning test in elderly subjects with memory complaints 149
The reversed clock drawing test phenomenon in Alzheimer's disease: A perfusion SPECT study 148
Cognitive impairment in late life bipolar disorder: Risk factors and clinical outcomes 148
The factorial structure of the mini mental state examination (MMSE) in Alzheimer's disease. 147
Limbic Network Derangement Mediates Unawareness of Apathy in Mild Cognitive Impairment due to Alzheimer’s Disease: Clues from [18F]FDG PET Voxel-Wise Analysis 146
Spect predictors of cognitive decline and alzheimer's disease in mild cognitive impairment 146
Cognitive-nigrostriatal relationships in de novo, drug-naïve Parkinson's disease patients: a [I-123]FP-CIT SPECT study. 146
How can we define a brain health chart? A narrative review and a proposal 145
Unawareness of Memory Deficit in Amnestic MCI: FDG-PET Findings 144
The Von Restorff effect in ageing and Alzheimer's disease. 144
MCI patients declining and not declining at mid-term follow-up: FDG PET findings. Annual Congress of the European Association of Nuclear Medicine 143
Anatomical and neurochemical bases of theory of mind in de novo Parkinson's Disease 142
Resting metabolic connectivity in prodromal Alzheimer's disease. A European Alzheimer Disease Consortium (EADC) project. 141
The Role of Hub and Spoke Regions in Theory of Mind in Early Alzheimer’s Disease and Frontotemporal Dementia 139
The value of SPECT in detecting Alzheimer-type neurodegeneration in mild cognitive impairment 137
Volume of interest-based [(18)F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study. 136
Cognitive function in patients with carotid stenosis: preliminary data on the use of the WAIS-R. 135
What predicts future cognitive decline in de novo Parkinson’s disease (PD)? 132
Do we need a 99mTc-ECD template for SPM SPECT studies? 131
Mapping memory impairment and conversion patterns in aMCI patients: a combined VBM and PET study 131
The role of anterior prefrontal cortex in prospective memory: an exploratory FDG-PET study in early Alzheimer's disease 130
The 16 item-printed word version of the free and cued selective reminding test (FCSRT): normal values in an italian population 126
Cognitive correlates of nigrostriatal dysfunction in de novo Parkinson’s disease (PD) 126
The Free and Cued Selective Reminding Test: Discriminative Values in a Naturalistic Cohort 126
Clinical and biological underpinnings of longitudinal atrophy pattern progression in Alzheimer's disease 125
The influence of nigrostriatal dopaminergic dysfunction on cognition of de novo Parkinson's disease patients 125
Performance of [18F] FDG-PET in 142 MCI patients with at least 2 years clinical follow up: a multicentric study of the European Alzheimer Disease Consortium (EADC) 125
Principal component analysis of FDG PET in amnestic MCI 124
Unawareness of memory deficit in amnestic MCI: FDG-PET findings. 124
Dopaminergic Activity and Cognitive Function in de novo Parkinson Disease patients: an 18F-DOPA PET/CT study 123
Tracking the progression of Alzheimer's disease: Insights from metabolic patterns of SOMI stages 121
MMSE factorial analysis in Alzheimer’s disease. 121
Italian validation of the Wagnild and Young Resilience Scale: a perspective to rheumatic disease Clin Exp Rheumatol 121
REMeDio: a proof-of-concept neuroprotection study for prodromal synucleinopathies 121
Clinical and metabolic profiles in behavioural frontotemporal dementia: Impact of age at onset 119
SPECT-Memory correlation in very mild Alzheimer’s disease. Effect of correlation for the severity of global cognitive impairment. 117
Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease. 117
Dehydroepiandrosterone sulphate and its correlation with clinical and hormonal parameters in eating disorders. 116
Metabolic Networks Involved in Cognitive Reserve in Prodromal Alzheimer's Disesase (pAD): A European Alzheimer's Disease Consortium (EADC) Project 116
Predicting the transition from normal aging to Alzheimer's disease: A statistical mechanistic evaluation of FDG-PET data 116
Neuroprogression as an illness trajectory in bipolar disorder: A selective review of the current literature 116
Principal component analysis of FDG PET in amnestic MCI 113
Stratification Tools for Disease-Modifying Trials in Prodromal Synucleinopathy 113
Funzioni attentive nell’anoressia nervosa: dati neurofisiologici preliminar 110
Dopaminergic and Serotonergic Degeneration and Cortical [18 F]Fluorodeoxyglucose Positron Emission Tomography in De Novo Parkinson's Disease 109
Integrated neurophysiological approach to Parkinson’s disease: preliminary data. 108
Discrepancy Between Patient and Caregiver Estimate of Apathy Predicts Dementia in Patients with Amnestic Mild Cognitive Impairment 107
Manuale del Caregiver – Per chi si prende cura della persona malata di Alzheimer 105
Cortical sources of awakening scalp EEG in eating disorders. 105
The need of appropriate brain spect templates for spm comparisons 104
Consistency of neuropsychiatric syndromes across dementias: Results from the european alzheimer disease consortium. Part ii 103
The visual search test: analysis of sensitivity of the global score and of the three items in mild Alzheimer’s disease 101
Evidence of posterior cortical dysfunction in de novo, drug-naïve Parkinson’s disease (PD) 100
A case of Huntington disease-like 2 in a patient of African ancestry: the everlasting support of clinical examination in the molecular era 99
Functional neuroimaging in de novo Parkinson's disease with REM sleep behaviour disorder 99
Semantic memory impairment and geographic space recognition in Alzheimer’s disease 99
Polysomnographic correlates of sleep disturbances in de novo, drug naïve Parkinson's Disease 99
Is Euro a cognitive chellenge for the elderly? 97
Totale 15.102
Categoria #
all - tutte 50.829
article - articoli 40.743
book - libri 0
conference - conferenze 9.337
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 749
Totale 101.658


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.226 32 66 114 151 52 83 67 256 50 116 50 189
2022/20231.355 102 95 21 147 211 222 4 116 248 18 148 23
2023/2024785 44 104 10 91 68 139 52 42 40 22 53 120
2024/20252.335 82 164 52 160 277 280 230 358 111 114 247 260
2025/20264.101 557 141 211 304 501 297 612 219 370 383 262 244
2026/2027972 972 0 0 0 0 0 0 0 0 0 0 0
Totale 16.019